Creating a new treatment to prevent tick-borne diseases
Developing a Potent Broad-Spectrum Prophylactic for Tickborne Disease
['FUNDING_OTHER'] · PLANET BIOTECHNOLOGY, INC. · NIH-10925734
This study is testing a new protein treatment that could help prevent Lyme Disease and Relapsing Fever with just one injection a year, making it suitable for everyone, including those with weaker immune systems, and aims to make it safe and effective for the whole tick season.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | PLANET BIOTECHNOLOGY, INC. (nih funded) |
| Locations | 1 site (HAYWARD, UNITED STATES) |
| Trial ID | NIH-10925734 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel protein treatment called Fc3/SCR(19-20) that will be administered as an annual injection to prevent Lyme Disease and Relapsing Fever. Unlike traditional vaccines, this treatment does not rely on stimulating the immune system, making it potentially effective for both healthy individuals and those with compromised immune systems. The research aims to enhance the protein's bioavailability, safety, and longevity to ensure effective protection throughout the tick season. The project involves collaboration between two research groups to optimize the production and testing of this innovative treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of tick-borne diseases, including those living in endemic areas or those who frequently engage in outdoor activities.
Not a fit: Patients who are already infected with Lyme Disease or Relapsing Fever may not benefit from this preventative treatment.
Why it matters
Potential benefit: If successful, this research could provide a reliable and accessible method for preventing tick-borne diseases in a wide range of patients.
How similar studies have performed: While this approach is innovative and not widely tested, previous research has shown promise in developing plant-produced proteins for medical use.
Where this research is happening
HAYWARD, UNITED STATES
- PLANET BIOTECHNOLOGY, INC. — HAYWARD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WYCOFF, KEITH — PLANET BIOTECHNOLOGY, INC.
- Study coordinator: WYCOFF, KEITH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.